Subhashree Misra

Subhashree Misra

Director Director DIN 08489189
DIN 08489189 First appointment Jun 2019 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2019
Shareholding value •••• Premium profile

About Subhashree Misra

Data last updated:

Subhashree Misra was a Director at Heredity Lifesciences Private Limited (2019–2023) and Heredity Biosciences Llp (2021–2023). The companies operate in Business Services and Research & Development.

DIN 08489189
Primary Designation Director
Industry Business Services
First Appointment 01 Jun 2019

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jun 20192018₹34 Lakh (FY 2025)Active
08 Dec 20212021Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Heredity Lifesciences Private Limited
Heredity Biosciences Llp
Premium access

Shareholding and investment profile for Subhashree Misra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subhashree Misra

Subhashree Misra was first appointed on 01 Jun 2019 as Director at Heredity Lifesciences Private Limited. The most recent appointment on record is 08 Dec 2021 at Heredity Biosciences Llp.

Subhashree Misra held 2 earlier board appointments: Heredity Lifesciences Private Limited (Director, 01 Jun 2019 to 31 Jul 2023); Heredity Biosciences Llp (08 Dec 2021 to 01 Jun 2023).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available